Cascadian Therapeutics, Inc. CASC
No live quote for CASC yet.
Revenue & Expenses
Latest period ending Dec 31, 2017 · select a line to chart its full history
Income statement
| Fiscal year | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 | FY 2015 Dec 31, 2015 | FY 2014 Dec 31, 2014 | FY 2013 Dec 31, 2013 |
|---|---|---|---|---|---|
| -58.09M | -64.83M | -32.79M | -50.84M | -41.22M | |
| -56.93M | -57.70M | -32.58M | -49.96M | -38.76M | |
| -1.21 | -3.13 | -2.02 | -3.86 | -3.72 |
Balance sheet
| Fiscal year | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 | FY 2015 Dec 31, 2015 | FY 2014 Dec 31, 2014 | FY 2013 Dec 31, 2013 |
|---|---|---|---|---|---|
| 16.78M | 13.72M | 27.85M | 10.45M | 9.28M | |
| 120.83M | 83.27M | 96.57M | 103.10M | 77.75M | |
| 11.79M | 8.91M | 12.84M | 11.84M | 6.20M | |
| 109.04M | 74.36M | 83.73M | 91.27M | 71.55M |
Cash flow
| Fiscal year | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 | FY 2015 Dec 31, 2015 | FY 2014 Dec 31, 2014 | FY 2013 Dec 31, 2013 |
|---|---|---|---|---|---|
| -49.98M | -36.73M | -28.78M | -48.37M | -36.34M | |
| -35.34M | -20.98M | 23.70M | 9.17M | -2.71M | |
| 88.38M | 43.58M | 22.47M | 40.37M | 26.07M | |
| -114.00K | -147.00K | -771.00K | -380.00K | -252.00K | |
| 3.06M | -14.13M | 17.40M | 1.18M | -12.99M |